211 related articles for article (PubMed ID: 11231370)
1. Role of diuretics in the preservation of residual renal function in patients on continuous ambulatory peritoneal dialysis.
Medcalf JF; Harris KP; Walls J
Kidney Int; 2001 Mar; 59(3):1128-33. PubMed ID: 11231370
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of furosemide in patients on peritoneal dialysis.
Flinn A; Ledger S; Blake P
CANNT J; 2006; 16(3):40-4. PubMed ID: 17061696
[TBL] [Abstract][Full Text] [Related]
3. Acute effects of high-dose furosemide on residual renal function in CAPD patients.
van Olden RW; Guchelaar HJ; Struijk DG; Krediet RT; Arisz L
Perit Dial Int; 2003; 23(4):339-47. PubMed ID: 12968841
[TBL] [Abstract][Full Text] [Related]
4. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function.
De Vecchis R; Ciccarelli A; Ariano C; Cioppa C; Giasi A; Pucciarelli A; Cantatrione S
Minerva Cardioangiol; 2011 Dec; 59(6):543-54. PubMed ID: 21330961
[TBL] [Abstract][Full Text] [Related]
5. Long-term follow-up of body size indices, residual renal function, and peritoneal transport characteristics in continuous ambulatory peritoneal dialysis.
Twardowski ZJ; Moore HL; Prowant BF; Satalowich R
Adv Perit Dial; 2009; 25():155-64. PubMed ID: 19886338
[TBL] [Abstract][Full Text] [Related]
6. [The effect of the number of peritonitis episodes on peritoneal membrane function].
Jovanović D; Nesić V; Dimitrijević Z
Srp Arh Celok Lek; 1999; 127(1-2):28-31. PubMed ID: 10377837
[TBL] [Abstract][Full Text] [Related]
7. Independent effects of residual renal function and dialysis adequacy on nutritional status and patient outcome in continuous ambulatory peritoneal dialysis.
Szeto CC; Lai KN; Wong TY; Law MC; Leung CB; Yu AW; Li PK
Am J Kidney Dis; 1999 Dec; 34(6):1056-64. PubMed ID: 10585315
[TBL] [Abstract][Full Text] [Related]
8. High correlation between clearance of renal protein-bound uremic toxins (indoxyl sulfate and p-cresyl sulfate) and renal water-soluble toxins in peritoneal dialysis patients.
Huang WH; Hung CC; Yang CW; Huang JY
Ther Apher Dial; 2012 Aug; 16(4):361-7. PubMed ID: 22817125
[TBL] [Abstract][Full Text] [Related]
9. Evolution of clinical parameters and peritoneal function in a cohort of CAPD patients followed over 7 years.
Faller B; Lameire N
Nephrol Dial Transplant; 1994; 9(3):280-6. PubMed ID: 8052436
[TBL] [Abstract][Full Text] [Related]
10. Adequacy and nutrition in the absence of residual renal function in peritoneal dialysis.
Canale R; Barone RJ; Gimenez NS; Santopietro M; Ramirez L; Palliotti A; Romero P; Amado D
Adv Perit Dial; 2001; 17():230-4. PubMed ID: 11510282
[TBL] [Abstract][Full Text] [Related]
11. [Furosemide and metolazone: a highly effective diuretic combination].
Furrer J; Hess OM; Kuhlmann U; Satz N; Siegenthaler W
Schweiz Med Wochenschr; 1980 Nov; 110(48):1825-9. PubMed ID: 7280609
[TBL] [Abstract][Full Text] [Related]
12. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
Licata G; Di Pasquale P; Parrinello G; Cardinale A; Scandurra A; Follone G; Argano C; Tuttolomondo A; Paterna S
Am Heart J; 2003 Mar; 145(3):459-66. PubMed ID: 12660669
[TBL] [Abstract][Full Text] [Related]
13. Furosemide does not improve renal recovery after hemofiltration for acute renal failure in critically ill patients: a double blind randomized controlled trial.
van der Voort PH; Boerma EC; Koopmans M; Zandberg M; de Ruiter J; Gerritsen RT; Egbers PH; Kingma WP; Kuiper MA
Crit Care Med; 2009 Feb; 37(2):533-8. PubMed ID: 19114909
[TBL] [Abstract][Full Text] [Related]
14. The comparison of the diuretic and natriuretic efficacy of continuous and bolus intravenous furosemide in patients with chronic kidney disease.
Sanjay S; Annigeri RA; Seshadri R; Rao BS; Prakash KC; Mani MK
Nephrology (Carlton); 2008 Jun; 13(3):247-50. PubMed ID: 18315706
[TBL] [Abstract][Full Text] [Related]
15. Nutritional parameters in diabetic patients on CAPD.
Scanziani R; Dozio B; Bonforte G; Surian M
Adv Perit Dial; 1996; 12():280-3. PubMed ID: 8865919
[TBL] [Abstract][Full Text] [Related]
16. Clinical experience with low-dose continuous infusion of furosemide in acute heart failure: assessment of efficacy and safety.
Ng TM; Hshieh S; Chan CY; Elkayam U
J Cardiovasc Pharmacol Ther; 2012 Dec; 17(4):373-81. PubMed ID: 22610091
[TBL] [Abstract][Full Text] [Related]
17. Effect of radio contrast media on residual renal function in peritoneal dialysis patients--a prospective study.
Dittrich E; Puttinger H; Schillinger M; Lang I; Stefenelli T; Hörl WH; Vychytil A
Nephrol Dial Transplant; 2006 May; 21(5):1334-9. PubMed ID: 16046499
[TBL] [Abstract][Full Text] [Related]
18. Residual renal function in children treated with continuous ambulatory peritoneal dialysis or automated peritoneal dialysis--a preliminary study.
Roszkowska-Blaim M; Skrzypczyk P; Drozdz D; Pietrzyk JA
Adv Perit Dial; 2009; 25():103-9. PubMed ID: 19886329
[TBL] [Abstract][Full Text] [Related]
19. Brain natriuretic peptide enhances renal actions of furosemide and suppresses furosemide-induced aldosterone activation in experimental heart failure.
Cataliotti A; Boerrigter G; Costello-Boerrigter LC; Schirger JA; Tsuruda T; Heublein DM; Chen HH; Malatino LS; Burnett JC
Circulation; 2004 Apr; 109(13):1680-5. PubMed ID: 15023890
[TBL] [Abstract][Full Text] [Related]
20. The effect of peritoneal dialysis method on residual renal function in children.
Roszkowska-Blaim M; Skrzypczyk P; Jander A; Tkaczyk M; Bałasz-Chmielewska I; Zurowska A; Drozdz D; Pietrzyk JA
Adv Perit Dial; 2012; 28():112-9. PubMed ID: 23311226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]